• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Hungary Pharmaceutical Market Analysis, 2010-2014 Product Image

Hungary Pharmaceutical Market Analysis, 2010-2014

  • Published: August 2010
  • Region: Hungary
  • 106 pages
  • Venn Research Inc

FEATURED COMPANIES

  • Almirall Prodesfarma SA
  • Astellas Pharma
  • AstraZeneca PLC
  • EGIS Pharmaceuticals Plc
  • Gedeon Richter Ltd
  • GlaxoSmithKline Plc
  • MORE

Having displayed fluctuating growth rates in the years 2005-2009 the Hungary pharmaceuticals market is expected to stabilize and perform low growth rates over the years up to 2014.

The Hungary pharmaceuticals market generated total revenues of $2,706.1 million in 2009, representing a compound annual growth rate (CAGR) of 4.7% for the period spanning 2005-2009. In comparison, the Polish and Czech markets grew with CAGRs of 5.8% and 10% respectively, over the same period, to reach respective values of $6,860.8 million and $2,867.5 million in 2009.

Cardiovascular sales proved the most lucrative for the Hungary pharmaceuticals market in 2009, ge-nerating total revenues of $581.8 million, and equivalent to 21.5% of the market's overall value. In comparison, sales of central nervous system generated revenues of $507.3 million in 2009, equating to 18.7% of the market's aggregate revenues.

This report highlights the Hungary pharmaceutical sector in terms of market share, key trends, market players and competitive scenario in the market.

Key Highlights:
- Current market scenario of Hungary pharmaceutical market, by revenue, geographic regions, product types, and READ MORE >

1 Hungary Pharmaceuticals Market, 2010
1.1 Quick Glance at the Market
1.2 Market Scenario
2 Hungary Pharmaceuticals Market, By Categories, 2010
3 Hungary Pharmaceuticals Market, By Market Players, 2010
4 Hungary Pharmaceuticals Market Outlook, 2014
5 Hungary Pharmaceuticals Market - Competitive Analysis
6 Company Profiles
6.1 Almirall Prodesfarma SA
6.1.1 Key Financials
6.1.2 Overview
6.1.3 Subsidiaries
6.1.4 Products and Services Analysis
6.1.5 Research and Development
6.2 Astellas Pharma
6.2.1 Key Financials
6.2.2 Overview
6.2.3 Subsidiaries
6.2.4 Products And Services Analysis:
6.2.5 SWOT Analysis
6.2.6 Company View
6.3 AstraZeneca PLC
6.3.1 Overview
6.3.2 Subsidiaries
6.3.3 Products and Services Analysis
6.3.4 Competitor Analysis
6.3.5 SWOT Analysis
6.4 The Menarini Group
6.4.1 Overview
6.4.2 Subsidiaries
6.4.3 Competitor Analysis
6.4.4 SWOT Analysis
6.5 EGIS Pharmaceuticals Plc
6.5.1 Overview
6.5.2 Subsidiaries
6.5.3 Products and Services Analysis
6.5.4 SWOT Analysis
6.6 Gedeon Richter Ltd
6.6.1 Overview
6.6.2 Subsidiaries
6.6.3 Competitor Analysis
6.6.4 SWOT Analysis
6.6.5 Investment Analysis
6.7 GlaxoSmithKline Plc
6.7.1 Key Financials
6.7.2 Overview
6.7.3 Subsidiaries
6.7.4 Products and Services Analysis
6.7.5 Competitor Analysis
6.7.6 SWOT Analysis
6.7.7 Investment Analysis
6.8 Les Laboratoires Servier
6.8.1 Overview
6.8.2 Competitor Analysis
6.8.3 SWOT Analysis
6.9 Novartis AG
6.9.1 Key Financials
6.9.2 Overview
6.9.3 Segments
6.9.4 Products and Services Analysis
6.9.5 Competitor Analysis
6.9.6 SWOT Analysis
6.10 Nycomed International Management GmbH
6.10.1 Key Financials
6.10.2 Overview
6.10.3 Products and Services Analysis
6.10.4 Competitor Analysis
6.10.5 SWOT Analysis
6.11 Orifarm A/S
6.11.1 Overview
6.12 Pharmstandard
6.12.1 Overview

List of Tables:
Table 1: Hungary Pharmaceuticals Market, ($ Billions) 2005-2010
Table 2: Hungary Pharmaceuticals Market, By Categories, 2010
Table 3: Hungary Pharmaceuticals Market, By Market Players, 2010
Table 4: Hungary Pharmaceuticals Market Outlook, ($Billion) 2011-2014
Table 4: Almirall Prodesfarma SA - Key Financials, 2008-2009
Table 5: Almirall Prodesfarma SA Sales, By Distribution Channels
Table 6: Almirall Prodesfarma SA Sales, By Geography
Table 7: Almirall Prodesfarma SA Sales, By Therapeutic Area
Table 8: Almirall Prodesfarma SA Sales, By Brand Names
Table 9: Astellas Pharma - Key Financials, 2008-2010
Table 10: Astellas Pharma - Historical Stock Information
Table 11: Astellas Pharma Sales, By Geography
Table 12: Astellas Pharma Sales, By Products
Table 13: AstraZeneca Sales, By Products, 2009
Table 14: AstraZeneca Sales, By Geography, 2009
Table 15: The Menarini Group Sales 2009
Table 16: The Menarini Group Employees, 2009
Table 17: Gedeon Richter Plc., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2010
Table 18: Gedeon Richter Plc., Pharmaceuticals & Healthcare Deals By Type, 2005 to YTD 2010
Table 19: GlaxoSmithKline Plc - Key Financials
Table 20: GlaxoSmithKline Plc - Histroical Stock Information
Table 21: GlaxoSmithKline Plc Sales, By Geography, 2009
Table 22: GlaxoSmithKline Plc Sales, By Products and Services, 2009
Table 23: GlaxoSmithKline plc, Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2010
Table 24: GlaxoSmithKline plc, Pharmaceuticals & Healthcare Deals By Type, 2005 to YTD 2010
Table 25: GlaxoSmithKline plc, Pharmaceuticals & Healthcare, Deals By Region, 2005 to YTD 2010
Table 26: GlaxoSmithKline plc, Pharmaceuticals & Healthcare, Deals By Sector, 2005 to YTD 2010
Table 27: Novartis AG - Key Financials
Table 28: Novartis AG - Historical Stock Information
Table 29: Novartis AG Sales, By Products and Servces, 2009
Table 30: Novartis AG Pharmaceuticals Sales, 2009
Table 31: Novartis AG Sales, By Geogrphy, 2009
Table 32: Nycomed International Management GmbH - Key Financials
Table 33: Orifarm A/S - Key Financials

List of Figures:
Figure 1: Hungary Pharmaceuticals Market, ($ Billions) 2005-2010
Figure 2: Hungary Pharmaceuticals Market, By Categories, 2010
Figure 3: Hungary Pharmaceuticals Market, By Market Players, 2010
Figure 4: Hungary Pharmaceuticals Market Outlook, ($Billion) 2011-2014
Figure 6: Almirall Prodesfarma SA Sales, By Geography
Figure 7: Almirall Prodesfarma SA - Research and Development Growth, 2011-2013

Almirall Prodesfarma SA
Astellas Pharma
AstraZeneca PLC
The Menarini Group
EGIS Pharmaceuticals Plc
Gedeon Richter Ltd
GlaxoSmithKline Plc
Les Laboratoires Servier
Novartis AG
Nycomed International Management GmbH
Orifarm A/S
Pharmstandard

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos